Focus on Women’s Mental Health

Page 3

Recently published articles about Focus on Women’s Mental Health

JCP
Living in a Pharmacologically Imperfect World
Editorial

October 12, 2022

Joseph F. Goldberg, MD, comments on prescription of valproate in women of reproductive potential, and the risk-benefit analysis involved with choosing the least imperfect treatment option.
JCP
Valproate Prescribing in Individuals of Childbearing Age
Letter to the Editor

October 12, 2022

Camille Tastenhoye, MD, and colleagues share data from a tertiary care women’s hospital that highlight opportunities for improvement in valproate prescribing practices.
, , , et al
JCP
Prescribing Guideline for Valproic Acid and Women of Reproductive Potential: Forget It Exists
Editorial

October 12, 2022

Marlene P. Freeman, MD, outlines reasons not to prescribe valproic acid in women of reproductive potential.
JCP
Maternal Postnatal Depression and Infant Immunizations
Original Research

June 13, 2022

The relationship between maternal postnatal depression and infant vaccination is uncertain. This study examined whether infants of mothers who sought support for postnatal depression were less likely to receive...
, ,
JCP
Pregnancy Outcomes With First-Trimester SGA Exposure
Original Research

June 8, 2022

In Japan, information regarding the effects of antipsychotics on the fetus during pregnancy is limited. This Japanese study examined the association between the use of antipsychotics during pregnancy and...
, , , et al
JCP
Original Research

January 18, 2022

The impact of biological rhythms on mood or anxiety during the peripartum period is largely unknown. This study examined changes in sleep and biological rhythms, melatonin levels, and light...
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe